OWLT
Owlet Inc
NYSE: OWLT · HEALTHCARE · MEDICAL DEVICES
$4.86
-6.54% today
Updated 2026-05-07
Market cap
$142.34M
P/E ratio
—
P/S ratio
1.35x
EPS (TTM)
$-2.31
Dividend yield
—
52W range
$4 – $17
Volume
0.3M
Owlet Inc (OWLT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $49.80M | $75.40M | $75.84M | $69.20M | $54.01M | $78.06M | $105.70M |
| Revenue growth (YoY) | — | +51.4% | +0.6% | -8.8% | -22.0% | +44.5% | +35.4% |
| Cost of revenue | $26.90M | $39.53M | $40.78M | $45.89M | $31.42M | $38.75M | $52.20M |
| Gross profit | $22.90M | $35.88M | $35.06M | $23.31M | $22.59M | $39.31M | $53.50M |
| Gross margin | 46.0% | 47.6% | 46.2% | 33.7% | 41.8% | 50.4% | 50.6% |
| R&D | $10.61M | $10.46M | $21.43M | $27.90M | $10.35M | $9.80M | $14.10M |
| SG&A | $13.17M | $13.14M | $32.34M | $41.55M | $27.34M | $33.97M | $29.20M |
| Operating income | $-17.05M | $-6.99M | $-55.79M | $-84.62M | $-28.63M | $-20.22M | $-8.30M |
| Operating margin | -34.2% | -9.3% | -73.6% | -122.3% | -53.0% | -25.9% | -7.9% |
| EBITDA | $-16.51M | $-8.25M | $-42.71M | $-75.53M | $-27.49M | $-9.47M | $-7.80M |
| EBITDA margin | -33.1% | -10.9% | -56.3% | -109.1% | -50.9% | -12.1% | -7.4% |
| EBIT | $-17.05M | $-9.12M | $-43.84M | $-78.20M | $-29.70M | $-10.85M | $-8.30M |
| Interest expense | $0.00 | $1.38M | $27.83M | $1.10M | $3.19M | $1.63M | $3.40M |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-17.85M | $-10.52M | $-71.70M | $-79.34M | $-32.90M | $-12.54M | $-41.90M |
| Net income growth (YoY) | — | +41.1% | -581.5% | -10.6% | +58.5% | +61.9% | -234.2% |
| Profit margin | -35.8% | -14.0% | -94.5% | -114.6% | -60.9% | -16.1% | -39.6% |